These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 26377485

  • 1. The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia.
    Wang J, Hao J, He N, Ji C, Ma D.
    Turk J Haematol; 2016 Sep 05; 33(3):180-6. PubMed ID: 26377485
    [Abstract] [Full Text] [Related]

  • 2. CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.
    Kim SY, Im K, Park SN, Kwon J, Kim JA, Lee DS.
    Am J Clin Pathol; 2015 May 05; 143(5):635-44. PubMed ID: 25873496
    [Abstract] [Full Text] [Related]

  • 3. Calreticulin exon 9 mutations in myeloproliferative neoplasms.
    Ha JS, Kim YK.
    Ann Lab Med; 2015 Jan 05; 35(1):22-7. PubMed ID: 25553276
    [Abstract] [Full Text] [Related]

  • 4. Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL.
    Wang Y, Ran F, Lin J, Zhang J, Ma D.
    Technol Cancer Res Treat; 2023 Jan 05; 22():15330338231154092. PubMed ID: 36744404
    [Abstract] [Full Text] [Related]

  • 5. CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.
    Ojeda MJ, Bragós IM, Calvo KL, Williams GM, Carbonell MM, Pratti AF.
    Hematology; 2018 May 05; 23(4):208-211. PubMed ID: 28990497
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.
    Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.
    Int J Hematol; 2018 Jun 05; 107(6):673-680. PubMed ID: 29464483
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms.
    Wiriyaukaradecha K, Nimsanor S, Tantirukdham N, Tongsom J, Bunyoo C, Soonklang K, Sritana N, Auewarakul C.
    Asian Pac J Cancer Prev; 2022 May 01; 23(5):1671-1678. PubMed ID: 35633552
    [Abstract] [Full Text] [Related]

  • 11. Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features.
    Loghavi S, Bueso-Ramos CE, Kanagal-Shamanna R, Ok CY, Salim AA, Routbort MJ, Mehrotra M, Verstovsek S, Medeiros LJ, Luthra R, Patel KP.
    Am J Clin Pathol; 2016 Mar 01; 145(3):418-27. PubMed ID: 27124925
    [Abstract] [Full Text] [Related]

  • 12. Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.
    Guo H, Chen X, Tian R, Chang J, Li J, Tan Y, Xu Z, Ren F, Zhao J, Pan J, Zhang N, Wang X, He J, Yang W, Wang H.
    PLoS One; 2015 Mar 01; 10(9):e0138250. PubMed ID: 26375990
    [Abstract] [Full Text] [Related]

  • 13. JAK2, CALR, and MPL Mutations in Egyptian Patients With Classic Philadelphia-negative Myeloproliferative Neoplasms.
    Soliman EA, El-Ghlban S, El-Aziz SA, Abdelaleem A, Shamaa S, Abdel-Ghaffar H.
    Clin Lymphoma Myeloma Leuk; 2020 Oct 01; 20(10):e645-e651. PubMed ID: 32591258
    [Abstract] [Full Text] [Related]

  • 14. Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
    Ahmed RZ, Rashid M, Ahmed N, Nadeem M, Shamsi TS.
    Asian Pac J Cancer Prev; 2016 Oct 01; 17(3):923-6. PubMed ID: 27039813
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Mutation of CALR Gene in Patients with Chronic Myeloproliferative Neoplasm and Its Clinical Significance].
    Tang Q, Zhang XW, Xia L, Jiang NK.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb 01; 25(1):151-156. PubMed ID: 28245393
    [Abstract] [Full Text] [Related]

  • 17. Somatic mutations of calreticulin in myeloproliferative neoplasms.
    Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D, Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant'Antonio E, Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M, Schönegger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G, Cazzola M, Kralovics R.
    N Engl J Med; 2013 Dec 19; 369(25):2379-90. PubMed ID: 24325356
    [Abstract] [Full Text] [Related]

  • 18. The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.
    Lin Y, Liu E, Sun Q, Ma J, Li Q, Cao Z, Wang J, Jia Y, Zhang H, Song Z, Ai X, Shi L, Feng X, Li C, Wang J, Ru K.
    Am J Clin Pathol; 2015 Jul 19; 144(1):165-71. PubMed ID: 26071474
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms.
    Grinsztejn E, Percy MJ, McClenaghan D, Quintana M, Cuthbert RJ, McMullin MF.
    Int J Lab Hematol; 2016 Feb 19; 38(1):102-6. PubMed ID: 26555437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.